Launch of a new cancer diagnostic platform: Oncobench®

This new genomic analysis platform is an exemplary outcome of the tight collaboration between a hospital (University Hospitals of Geneva, HUG) and bioinformatics experts (SIB), in order to develop cutting-edge clinical tools in the era of personalized medicine.

Developed hand-in-hand by the clinical pathology department of the HUG and SIB's Clinical Bioinformatics and Vital-IT groups, Oncobench® allows for a faster diagnosis of cancer. It decreases the overall time necessary to complete the analyses - from the tumoural sample to the clinical report delivered to the patient - from five to four days.
Importantly, as the platform is embedded on-premises, patients' data never leave the hospital, thereby ensuring the privacy of their data.
By setting high data-quality standards, Oncobench® is a first step towards a nationwide implementation of the Swiss Personalized Health Network (SPHN), in which SIB plays a pivotal role. The technology is intended to be shared with other hospitals in the near future.

Read the full press release (in French) here.

Press contact

marie dangles
Marie Dangles
Head of Communications

maia berman
Maïa Berman
Communications Manager

sylvie clottu
Sylvie Clottu
Communications Assistant
 

SIB Communications
communication@sib.swiss
+41 21 692 40 46